- authorisedPhase I and Phase II (Integrated)- Other
EXUROC Bladder Target - A phase Ib/ll study to determine the safety, tolerability, and efficacy of LP-184 treatment in patients with advanced/metastatic urothelial carcinoma
This clinical trial is testing a new cancer drug called LP-184 for adults with advanced bladder or urinary tract cancer. Doctors want to find out the safest dose to give, check for side effects, and see if the treatment can help shrink tumours or slow down the cancer.
Denmark - recruitingPhase I and Phase II (Integrated)- First administration to humans
TEMPLE - Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy
This study is testing new ways to treat cancer. It combines standard cancer drugs with newer immunotherapy to see if they work better together. Researchers are also looking for the best dose and how safe this new treatment is.
Denmark - recruiting
Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
This study looks at how well fertility preservation methods work for women who have had cancer or blood disorders. It also explores how these women use (or don't use) these options over time, and the emotional effects, aiming to improve future care.
France - recruitingNA
Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends
This study looks at a special liquid food given through a tube to people who need extra nutrition. We want to see how well people tolerate it and if they like it. It's for children and adults with conditions like Cerebral Palsy or cancer who need tube feeding.
United Kingdom - recruiting
Value of Analysing Under-utilised Leftover Tissue (VauLT)
This study looks at how we can get a better picture of a patient's cancer by blending leftover tumour tissue from surgery. This helps scientists understand the cancer more fully, potentially leading to better diagnoses and treatments.
United Kingdom - recruiting
Understanding immunE-related toXicities by multifACeT Profiling
This study looks at side effects of a type of cancer treatment called immunotherapy. Researchers will collect blood and stool samples from patients to understand why these side effects happen, helping to improve care for people with cancer.
United Kingdom - recruitingNA
A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent
This study looks at a new type of tube, called a stent, for people with kidney stones or cancer that affects their bladder tubes. The new stent aims to reduce pain and infections, making life better for patients and potentially reducing hospital visits.
United Kingdom - not yet recruitingNA
PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications
This study looks at whether checking and treating dental problems before chemotherapy for blood cancers can reduce side effects like mouth sores and infections. It aims to see if this dental care plan, called PRIOR, is safe and can work in hospitals.
United Kingdom - recruiting
PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments
This study looks at how people with cancer taking oral medications at home are supported through a special programme called Oncoral. It aims to understand how well these treatments work in real life and how to make care better for patients outside of the hospital.
France - active not recruiting
Comprehensive Segmental Revision System
This study looks at how well a special shoulder and elbow replacement system works for people with joint problems, arthritis, or after surgery for cancer or injuries. It will track patients for at least 10 years to understand their long-term outcomes and improve future treatments.
Canada · Denmark · United Kingdom - recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The MOMENTUM Study is tracking how a new type of advanced radiotherapy, called MR-Linac, works for people with different cancers. It aims to see if this treatment improves survival, controls cancer better, and enhances quality of life by using highly precise radiation guidance.
United States · Australia · Belgium